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Abstract
Primary cicatricial alopecia (PCA) is a group of inflammatory hair disorders that cause scarring and permanent hair loss.
Previous studies have implicated PPARc, a transcription factor that integrates lipogenic and inflammatory signals, in the
pathogenesis of PCA. However, it is unknown what triggers the inflammatory response in these disorders, whether the
inflammation is a primary or secondary event in disease pathogenesis, and whether the inflammatory reaction reflects an
autoimmune process. In this paper, we show that the cholesterol biosynthetic pathway is impaired in the skin and hair
follicles of PCA patients. Treatment of hair follicle cells with BM15766, a cholesterol biosynthesis inhibitor, or 7-
dehydrocholesterol (7-DHC), a sterol precursor, stimulates the expression of pro-inflammatory chemokine genes. Painting of
mouse skin with 7-DHC or BM15766 inhibits hair growth, causes follicular plugging and induces the infiltration of
inflammatory cells into the interfollicular dermis. Our results demonstrate that cholesterologenic changes within hair follicle
cells trigger an innate immune response that is associated with the induction of toll-like receptor (TLR) and interferon (IFN)
gene expression, and the recruitment of macrophages that surround the hair follicles and initiate their destruction. These
findings reveal a previously unsuspected role for cholesterol precursors in PCA pathogenesis and identify a novel link
between sterols and inflammation that may prove transformative in the diagnosis and treatment of these disorders.
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Introduction
Primary cicatricial alopecia (PCA) is a group of rare in-
flammatory disorders that is characterized by the permanent
destruction of the hair follicle. Ultimately, the hair follicle is
replaced with fibrous tissue, and progressive and permanent hair
loss occurs [1–3]. The etiology and pathogenesis of PCA remain
unclear, but PCA is currently treated as an inflammatory disorder
[2,4]. The treatment options for PCA are limited and are not very
effective in controlling the disease progression. A dearth of
information about the underlying molecular pathogenesis has
constituted the major obstacle in identifying effective new
treatments.
The diagnosis of PCA currently relies upon clinical observation
and histological analysis of the inflammatory cell infiltrate in the
infundibulum, which is the permanent portion of the hair follicle
(HF). Depending on the type of principal inflammatory cell
detected during the active phase of the disease, PCA is classified
into three categories: lymphocytic, including lichen planopilaris
(LPP), frontal fibrosing alopecia (FFA) and central centrifugal
cicatricial alopecia (CCCA); neutrophilic, including folliculitis
decalvans (FD) and tufted folliculitis (TF); and mixed, including
dissecting cellulitis (DC) [5]. In none of the PCA subtypes do we
know exactly why hair follicles begin to attract an inflammatory
infiltrate. Furthermore, the cellular composition of the inflamma-
tory infiltrate and the nature of its activated state are not well
characterized. Thus, it is not surprising that halting or reversing
the inflammation in PCA is often difficult.
The failure of the affected follicles to regenerate in PCA is
thought to be the result of irreversible changes in the permanent
portion of the hair follicles (HF), where the ‘‘bulge stem cells’’ are
located [6,7]. HF bulge stem cells are a unique population of adult
stem cells that are multi-potent and play a major role in skin
architecture, physiology and wound healing [8,9]. The permanent
loss of hair follicles in PCA is therefore a disastrous event for
normal skin function and regeneration. If the HF bulge stem cells
are destroyed, there is no possibility for hair follicle regeneration,
and permanent hair loss ensues. Thus, PCA offers an excellent
model for understanding disease mechanisms where epithelial
stem cell populations are targeted by an inflammatory attack.
Our previous studies implicated the peroxisome proliferator-
activated receptor gamma (PPARc), a transcription factor that
belongs to the nuclear receptor family, in the pathogenesis of
PCA [10]. Nuclear receptors affect transcription through
multiple modes of action, including direct activation of genes,
ligand-independent repression, ligand-dependent repression, and
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including PPARc, modulate the expression of lipogenic and
inflammatory genes and have emerged as important regulators of
metabolic and inflammatory signaling. We previously reported
a loss of PPARc signaling in the PCA subtype LPP. Indeed, the
deletion of PPARc in K15-bulge stem cells in mutant mice
results in an LPP-like skin phenotype with progressive hair loss,
perifollicular inflammation and scarring alopecia [10]. Gene
expression profiling of the skin from PPARc knockout mice and
from scalp tissue in patients affected with LPP consistently
showed decreased expression of PPARc-regulated lipid metabolic
genes and increased expression of inflammatory genes [10].
Although PPARc has emerged as an important regulator of
lipogenic and inflammatory genes [11], the precise link between
specific lipid metabolic pathways and inflammation in the skin
and skin appendages is not fully understood [12].
In this manuscript, we demonstrate that the cholesterol
biosynthesis pathway is altered in all subtypes of PCA. We further
show that changes in cholesterol biosynthesis within hair follicle
cells trigger a pro-inflammatory response and induce the re-
cruitment of innate immune cells that initiate the destruction of
hair follicles in mouse skin and in PCA. Our results reveal
a previously unidentified role for cholesterol precursors in PCA
pathogenesis and identify a novel link between sterols and
inflammation that may prove transformative in the diagnosis
and treatment of these disorders.
Results
Altered Cholesterologenic Program in PCA
To identify the pathways underlying PCA pathogenesis, we
analyzed the gene expression profiles of paired unaffected (non-
lesional) and affected (lesional) scalp tissues from 12 lymphocytic
(LPP, CCCA, FFA) and 3 neutrophilic (TF) PCA patients. These
tissues were compared to normal scalp tissue (N=10 pooled) from
healthy individuals using Affymetrix microarrays. Principal
component analysis based on all downregulated genes and all
samples revealed a 68.5% variation between diseased and normal
samples in the first two principal components (Figure 1A–1D). The
unaffected (green ovoid) and affected (red ovoid) samples in each
PCA subset, including LPP (Figure 1A), CCCA (Figure 1B), FFA
(Figure 1C) and TF (Figure 1D), formed distinct groups and
showed a partial overlap. In contrast, the normal controls (N=10
pooled, blue ovoid) were well separated from both the unaffected
and the affected samples from the patients (Figure 1A–1D). In LPP
(Figure 1A), the normal controls lie within the plane of unaffected
samples. This is due to the smaller number of gene expression
changes in unaffected LPP compared to normal samples. These
analyses indicate a distinct gene expression profile of unaffected
scalp skin in all PCA subtypes. This gene expression profile has
some similarities to that of the affected scalp skin from the same
patients, but is markedly different from the profile of normal
healthy controls.
The most extensively downregulated gene clusters in PCA are
shown as a heat map (Figure 1E) and consist of 39 genes dedicated
to lipid metabolism. The majority of the altered transcripts
belonged to the cholesterol biosynthesis pathway. The remaining
transcripts were associated with a few predominant pathways,
including fatty acid metabolism, the aldehyde dehydrogenase-
related pathway for the oxidation of endogenous and xenobiotic
aldehydes and pathways involving the cytochrome P450 super-
family of enzymes, which catalyze many reactions in the synthesis
of cholesterol, steroids and other lipids. The downregulation of
genes involved in cholesterol biosynthesis in both unaffected and
affected tissue from patients with PCA suggests that these genes
are involved in the early changes in PCA pathogenesis.
The decreased expression of genes related to cholesterol
biosynthesis in PCA was confirmed in an independent set of
PCA samples by microarray analysis (Table S1) and real-time
PCR (Figure 1E). As shown in Table S1, the number of
cholesterol biosynthesis genes affected and the extent to which
they are downregulated differ in the different PCA subtypes. The
genes that encode DHCR7, HMGCS1 and SC5DL are down-
regulated in all subtypes; ACAT2, FDPS and PMVK are
downregulated in lymphocytic but not in neutrophilic PCA;
MVK is downregulated only in neutrophilic PCA; and MVD is
downregulated only in FFA (Gene names are included in
Glossary S1). We validated the microarray data using the real-
time PCR with primers specific for the two cholesterol bio-
synthesis genes, DHCR7 (Figure 1F) and EBP (Figure 1G).
DHCR7 was significantly downregulated in both the lymphocytic
and neutrophilic types of PCA, as shown in Figure 1F. In
contrast, the expression of EBP differed in the different subtypes.
EBP was significantly downregulated in the lymphocytic PCA
subtypes CCCA and FFA. However, the expression of EBP did
not significantly change in neutrophilic PCA. These data suggest
that, although cholesterol biosynthesis is decreased in all PCA
subtypes, different genes in this biosynthetic pathway are affected
in the different subtypes (Table S1 & Figure 1F–1G).
To determine the biological relevance of the gene expression
changes in PCA, we analyzed the microarray data with the
Ingenuity Pathway Analysis (IPA) software (www.ingenuity.com,
Ingenuity Systems Inc., Redwood City, CA, USA). IPA provides
the ability to map differentially expressed genes to fixed canonical
pathways and Toxlists. IPA-ToxH is a data analysis capability
within IPA that identifies biological mechanisms that are related to
toxicity (Toxlists) (on a molecular, cellular, and biochemical level).
Figure 2 summarizes the most significant Toxlists associated with
the gene expression changes observed in unaffected and affected
tissues from patients with LPP, CCCA, FFA and TF. Cholesterol
biosynthesis appears at the top of the Toxlist (Figure 2A–2F)
suggesting that it is the most significant toxic pathway associated
with the lymphocytic PCA subtypes. The other significant
pathways in lymphocytic PCA include fatty acid metabolism,
oxidative stress response, mitochondrial dysfunction and LXR/
RXR activation. In contrast, the oxidative stress response and
hypoxia-inducible factor (HIF) signaling are the most significant
toxic pathways associated with neutrophilic PCA (Figure 2G–2H).
As shown in Figure 2A–2F, although the Toxlists are remarkably
similar, there are also distinct differences between the different
subtypes of lymphocytic PCA.
Together, these observations suggest that cholesterol biosynthe-
sis is significantly decreased in PCA and is the most significant
toxic pathway associated with the lymphocytic PCA. The
cholesterol biosynthesis pathway is also affected in neutrophilic
PCA, albeit to a lesser extent. We have therefore identified a ‘‘pre-
PCA’’ gene expression signature in uninvolved tissue from PCA
patients. This signature is comprised of downregulated cholesterol
biosynthesis genes that may represent the earliest changes in
disease pathogenesis.
Increased Expression of Adaptive and Innate Immune
Genes in PCA
The comparison of gene expression profiles of PCA scalp skin
with healthy control skin by microarray analysis revealed that the
most prominently upregulated genes are those involved in the
immune and inflammatory responses (Figure 3). A principal
component analysis based on all upregulated genes in all samples
Sterols and Innate Immune Response in PCA
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unaffected and normal tissue in all PCA subtypes (Figures 3A–3D).
As shown in Figures 3A–3D, the unaffected tissue from PCA
patients (green ovoid) lies on the same plane as the pooled normal
control tissue (N=10 pooled, represented by the blue ovoid).
These data suggest that the expression of inflammatory genes is
altered in the affected tissue of PCA patients, and there is no
significant difference in the expression of inflammatory genes
between the unaffected tissue of PCA patients and normal
controls. The differential expression of immune response gene
clusters in the affected, but not unaffected, scalp skin of PCA
patients suggests that the inflammatory changes occur in the
‘‘active disease’’ and do not represent the earliest changes in PCA
pathogenesis.
A pathway analysis of the microarray data from affected scalp
tissue revealed that the innate and the adaptive immune pathways
are both upregulated in PCA (Figure 3E–3H). In LPP (Figure 3E),
the upregulated inflammatory pathways include the antigen
presentation pathway, communication between adaptive and
innate immune cells, B-cell development, interferon signaling,
crosstalk between dendritic and NK cells and Toll-like receptor
(TLR) signaling. The upregulated inflammatory pathways in
CCCA (Figure 3F) include atherosclerosis and integrin signaling,
lipid antigen presentation by CD1, CD28 signaling in T helper
Figure 1. Decreased expression of genes related to cholesterol biosynthesis and lipogenesis in PCA. Principal component analysis of
microarray data (downregulated genes) from lymphocytic (1A–1C) and neutrophilic (1D) cicatricial alopecia was performed with the Partek Genomics
Suite. The results of the analysis for LPP are shown in 1A, for CCCA in 1B, for FFA in 1C and for TF in 1D. The horizontal axis corresponds to principal
component 1 (PC1), the vertical axis corresponds to PC2 and the depth axis corresponds to PC3. The points are colored by group status: blue
represents normal samples (pooled), green represents unaffected samples and red represents affected cicatricial alopecia samples. The clusteringo f
data by samples suggests similarities in gene expression profiles. Unaffected and affected samples are clustered together in each subtype, which
suggests that the expression profiles of genes involved in cholesterol biosynthesis and lipogenesis are not significantly different among these
samples. The normal scalp tissue was significantly different from the unaffected and affected scalp samples from patients with LPP, CCCA, FFA and TF.
(E) Heat map of the 39 most significantly downregulated genes in patients with LPP (6 affected and 5 unaffected scalp samples) CCCA, FFA and TF (3
affected and 3 unaffected scalp samples each). The majority of the genes participated in cholesterol biosynthesis. The color bar below indicates the
level of expression. (F) Real-time PCR validation of DHCR7 gene expression in normal skin and in the PCA subtypes LPP, CCCA, FFA, TF and DF
(*p,0.05, **p,0.01). Compared with normal tissue, DHCR7 expression was significantly decreased in all PCA samples. The unpaired t-test was used
for statistical analysis. (G) Real-time PCR validation of EBP gene expression in skin from normal controls and patients with the PCA subtypes LPP,
CCCA, FFA, TF and DF (*p,0.05, **p,0.01). EBP expression was significantly decreased in the PCA subtypes TF, FFA and CCCA but not in DC, FD or
LPP. The unpaired t-test was used for statistical analysis. See also Figure S1 and Table S1.
doi:10.1371/journal.pone.0038449.g001
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major upregulated pathways include JAK/Stat signaling, B-cell
development, NK cell signaling, T-cell receptor and NFkB
signaling. The upregulated pathways in neutrophilic PCA (TF)
(Figure 3H) include B-cell development, T-cell receptor signaling,
NK cell signaling, T helper cell differentiation and IL-17A.
The predominantly upregulated inflammatory genes in PCA
are shown as a heat map (Figure 3I). Various genes were identified
in the ‘‘immune cluster,’’ including genes whose products control
the innate immune responses, such as the interleukin/Toll-like
receptor superfamily, interferon inducible proteins, and mono-
cyte/macrophage related proteins. Genes whose products are
required for the adaptive immune response, such as chemokine/
cytokine family members, T and B cell activation and survival
genes, genes encoding MAP kinases, members of the tumor
necrosis factor superfamily and the major histocompatibility
complex class I and class II genes, were also overexpressed in
PCA. The microarray data were validated by performing real-time
PCR for TLR4, TLR6, IFNa, IFNa7, NFkB and IFNc in tissues
from patients with lymphocytic and neutrophilic PCA. As shown
in Figure 4A–4H, real-time PCR with target-gene-specific primers
confirmed that Toll-like receptor (TLR4, TLR6), interferon (IFNa,
IFNa7, IFNc), pro-inflammatory cytokine (NFkB) and macrophage
activation factor (MMD, MCP1) genes are all significantly
upregulated in affected PCA tissue compared with unaffected
tissue from the same patients.
Intriguingly, the IFN signaling pathway and its target genes that
serve as a link between innate and adaptive immunity were
upregulated in affected but not unaffected tissue from patients with
all PCA subtypes (lymphocytic, neutrophilic and mixed), as shown
in Figures 4C, 4D, 4F & 4I. Interferons can modulate the
expression of several hundred genes encoding proteins that
participate in the antiviral defense, inflammation, adaptive
immunity and angiogenesis. The result is a characteristic pattern
of mRNA expression known as the "interferon signature." The
upregulation of interferon signature genes in LPP was confirmed
using IPA (Figure 4I, Table S2). The interferon-responsive
signature genes upregulated in LPP include type II interferon
(IFNc)-responsive genes (IRF1, TAP1, IFITM1, PSMB8, IFI35,
and IRF9) and type I interferon (IFNa)-responsive genes (IFIT1,
OAS1, IFITM1, MX1, IFIT3, IRF9, IFI35, and PSMB8), as shown
in Figure 4I and Table S2.
These data provide evidence for the involvement of the innate
and adaptive immune responses in the pathogenesis of PCA.
Figure 2. Ingenuity Pathways Analysis of the top toxic pathways in cicatricial alopecia. IPA-ToxH, a data analysis capability tool within the
Ingenuity Pathways Analysis, was used to analyze the microarray data and to determine the toxicity associated with the observed gene expression
changes in PCA. The figure shows the top toxicity lists (Toxlists) associated with gene expression changes in samples from unaffected and affected
scalp areas in patients with LPP, CCCA, FFA and TF. Cholesterol biosynthesis appears to be the most significant toxicity-related pathway associated
with the lymphocytic PCA subtypes.
doi:10.1371/journal.pone.0038449.g002
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a Pro-inflammatory Response in Hair Follicle Cells in vitro
Given the reciprocal expression pattern for genes related to
cholesterol biosynthesis (downregulated) and inflammation (upre-
gulated) in PCA, we hypothesized that a mechanistic link exists
between these diverse signaling pathways in hair follicles. To test
this hypothesis and to determine the physiological relevance of
decreased cholesterol biosynthesis in PCA, we studied the effects of
the cholesterol biosynthesis inhibitor BM15766 (a pharmacological
inhibitor of the enzyme DHCR7), and 7-dehydrocholesterol (7-
DHC) (a cholesterol precursor) on human hair follicle outer root
sheath (HHFORS) cells in vitro. The cholesterol biosynthesis
pathway involves $20 enzymatic reactions. As shown in Figure
S1, the last step in cholesterol biosynthesis is the conversion of 7-
DHC to cholesterol by 7-dehydrocholesterol reductase (DHCR7).
We selected the DHCR7 inhibitor BM15766 and the cholesterol
precursor 7-DHC for our studies because our data showed that the
expression of DHCR7 was consistently and significantly decreased
in all tested PCA samples (Figure 1F & Table S1). We suspected
that decreased expression of DHCR7 would cause an accumula-
tion of the cholesterol biosynthesis intermediate 7-DHC in hair
follicle cells.
Treatment of HHFORS cells with 7-DHC or BM15766
induced a pro-inflammatory response, as determined by global
gene expression profiling and real-time PCR (Figure 5). An IPA
analysis of the microarray data for 7-DHC- or BM15766-treated
HHFORS cells revealed a significant increase in the expression of
inflammatory genes (Figures 5A & 5B). We found that the most
significant pathways affected in 7-DHC-treated cells were the cell
mediated-immune response, immune cell trafficking, inflammato-
ry disease, the inflammatory response and the humoral immune
response (Figure 5A). The most significant pathways affected in
BM15766-treated cells were immune cell trafficking, the in-
flammatory response, immune cell disease, immunological disease
and the hematological response (Figure 5B). Intriguingly, the most
significant predicted networks identified by IPA analysis included
Figure 3. Increased expression of immune and inflammatory genes in PCA. The principal component analysis results for upregulated genes
from lymphocytic (A) LPP, (B) CCCA, (C) FFA and (D) neutrophilic (TF) cicatricial alopecia are shown. The normal and unaffected samples are clustered
together in each subtype, which suggests that the expression of immune and inflammatory genes is not significantly different among these samples.
Most samples from affected scalp areas in patients with PCA are clustered separately from normal controls and from samples of unaffected scalp skin
from PCA patients, which suggest that the expression of these genes differs between affected and unaffected samples. The top canonical pathways
from gene expression profiles in patients with (E) LPP, (F) CCCA, (G) FFA and (H) TF are shown. Red represents upregulated and green represents
downregulated genes in these pathways. The yellow graph line in E, F, G and H represents –log (p values). (I) Heat map of the most significantly
altered immune and inflammatory genes in LPP (6 affected and 5 unaffected samples), CCCA, FFA and TF (3 affected and 3 unaffected samples each)
is shown. The color bar below indicates the level of expression.
doi:10.1371/journal.pone.0038449.g003
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and the TLR6 network (Figure 5D, Table S3) in BM15766-treated
cells.
Real-time PCR confirmed that the expression of innate immune
and pro-inflammatory genes significantly increased in 7-DHC-
and BM15766-treated HHFORS cells compared with untreated
or vehicle-treated controls (Figure 5E–5I). The expression of TLR4
was significantly increased in HHFORS cells treated with 7-DHC
(,5-fold, p,0.05) or BM15766 (,18-fold, p,0.05), as shown in
Figure 5E. In contrast, TLR6 was specifically upregulated in cells
treated with BM15766 (,1.6-fold, p,0.01), but not in cells treated
with 7-DHC. After treatment with 7-DHC or BM15766, IFN-
a (,3-fold, p,0.05 and ,3.5-fold, p,0.05; Figure 5G), IFN-a7
(,3.5-fold, p,0.05 and ,4-fold, p,0.05; Figure 5H) and NFkB
(,1.7-fold, p,0.05 and ,2.25-fold, p,0.05; Figure 5I) were all
significantly upregulated in HHFORS cells, respectively. In
addition, real-time PCR showed that the expression of the TGFb1
gene was significantly upregulated in hair follicle cells after
treatment with BM15766 (Figure S2). These data suggest that the
inhibition of endogenous cholesterol biosynthesis or the accumu-
lation of cholesterol precursors induces a pro-inflammatory
response in human hair follicle cells in vitro.
Sterol Intermediates of Cholesterol Biosynthesis Inhibit
Hair Growth and Trigger an Innate Immune Response in
Mouse Skin
We next determined whether BM15766 and 7-DHC have the
same effects on mouse skin in vivo (Figure 6). Mouse hair cycle
stages are naturally synchronized in individual mice. However,
animals of the same age and from the same litter can exhibit
heterogeneity with respect to hair follicle cycling. Therefore, mice
in the telogen phase of hair growth cycle (7 weeks old) were
depilated to synchronize their hair cycle stages and painted every
day for 14 days with 7-DHC (a cholesterol precursor; see
Figure 4. Innate immune genes are upregulated in PCA. Real-time PCR validation of (A) TLR4, (B) TLR6, (C) IFNa, (D) IFNa7, (E) NFkB, (F) IFNc, (G)
MMD and (H) MCP1 in mixed (DC, DF), neutrophilic (TF, FD) and lymphocytic (FFA, LPP, CCCA) PCA. These genes are significantly upregulated in
affected tissue compared to unaffected tissue from the same patients (*p,0.05, **p,0.01). The unpaired t-test was used for statistical analysis.
Differences in the pattern of expression of these genes were observed in the different PCA subtypes. (I) IPA identified the interferon signaling
pathway or the ‘‘interferon-responsive signature’’ in the gene expression profiles of LPP. The intensity of the node color red indicates the degree of
upregulation, and the intensity of the color green indicates the degree of downregulation. Genes shown as uncolored nodes were not identified as
differentially expressed in our experiment and were integrated into the computationally generated networks based on the evidence stored in the IPA
knowledge base, which indicated a relevance to this network. The node shapes denote enzymes, phosphatases, kinases, peptidases, transmembrane
receptors, cytokines, transporters, translation factors, nuclear receptors and transcription factors. The interferon target genes IRF1, IRF8, IFNA5, IFNAR2,
IFIT3, IFITM1, MX1, OAS1 and IFI35 are significantly upregulated in LPP. See also Table S2.
doi:10.1371/journal.pone.0038449.g004
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see Figure 6B) or vehicle (ethanol or DMSO; see Figures 6A &
6B). The mice were then monitored for hair re-growth.
Histological changes were monitored by H&E staining of
paraffin-mounted mouse skin sections. At the end of 14 days,
hair growth was fully restored in the vehicle-treated mice.
Ethanol-treated mice are shown in Figure 6A and DMSO-
treated mice in Figure 6B. In stark contrast, the hair follicles in
mice treated with 7-DHC (Figure 6A) or BM15766 (Figure 6B)
did not re-grow. We therefore determined whether BM15766 or
7-DHC had an effect on catagen induction or on hair follicle
stem cells. As shown in Figure S2, real-time PCR showed that
the expression of the TGFb1 gene was significantly increased in
mouse skin tissue after treatment with BM15766. In addition, the
expression of SOX9 was significantly decreased both in
HHFORS cells in culture and in mouse skin after treatment
with 7-DHC and BM15766 (Figure S2).
H&E staining of mouse skin treated with 7-DHC or BM15766
showed epidermal thickening, follicular plugging and an increased
number of histiocytes in the dermis (Figure 6C & 6D). Tissue
macrophages in the inter-follicular dermis and surrounding hair
follicles were detected at higher magnification (100X) in H&E
stained skin sections from mice treated with 7-DHC or BM15766
(Figure 6E & 6F).
Macrophages are crucial initiators and regulators of the innate
and adaptive host defenses in the skin. Therefore, to corroborate
the H&E data, we stained the mouse skin sections with antibodies
to F4/80, which is a transmembrane protein present on the
surface of mouse macrophages. As shown in Figure S3, F4/80-
positive cells were observed in mice treated with 7-DHC and
BM15766 but not in vehicle-treated controls. Flow cytometry
analysis also revealed a significantly increased number of
macrophages (F4/80+ cells) in mouse skin that had been treated
with 7-DHC (8% increase; see Figure 6G) or with BM15766 (9%
Figure 5. Sterol intermediates of cholesterol biosynthesis trigger an inflammatory response in hair follicle cells. Inflammatory and
immune responses were the top biological functions affected by treatment of HHFORS cells with (A) 7-DHC or (B) BM15766. The most significant
biological functions affected, their p values and the number of differentially expressed genes (molecules) after each treatment were identified using
IPA. The difference between vehicle and 7-DHC or BM15766 treatments was defined as significant if a 1.5-fold or greater difference in the average
hybridization signal intensity with a p,0.05 using a two-tailed unpaired t-test was observed. Predicted interaction networks in hair follicle cells after
treatment with (C) 7-DHC and (D) BM15766 are shown. The TLR4 gene network was activated after 7-DHC treatment, and the TLR6 network was
activated after BM15766 treatment. Solid lines denote a direct relationship, and dotted lines denote an indirect relationship between two genes in
the network. A red node denotes an upregulated gene, and a green node denotes a downregulated gene, with the difference in intensity reflecting
the degree of change in the expression of differentially expressed genes in our dataset. The inflammatory functions and disease (fx) associated with
each TLR network were determined using IPA. See also Table S3. The real-time PCR validation of (E) TLR4, (F) TLR6, (G) IFNa, (H) IFNa7 and (I) NFkB gene
expression in 7DHC- and BM15766-treated hair follicle cells (*p,0.05, **p,0.01) is shown. The unpaired t-test was used for statistical analysis.
doi:10.1371/journal.pone.0038449.g005
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& 6H). To determine if macrophages were present in the tissue of
patients with PCA, we stained scalp skin sections from patients
with lymphocytic and neutrophilic PCA with antibodies to CD68,
a 110-kD transmembrane glycoprotein that is highly expressed in
human monocytes, including tissue macrophages. Figure S4 shows
a microphotograph of CD68+ cells in the lymphocytic (LPP,
CCCA, and FFA) and neutrophilic (TF) subtypes of PCA. These
results suggest a role for macrophages in the pathogenesis of PCA.
To elucidate the mechanisms and signaling pathways un-
derlying our findings, we performed gene expression profiling and
IPA analysis to compare mouse skin that had been treated with 7-
DHC and BM15766 with untreated controls. The inflammatory
and immune pathways that were upregulated in 7-DHC-treated
mouse skin included acute phase response signaling, SLE
signaling, dendritic cell maturation and interferon signaling
(Figure 7A). Pathways that were upregulated in BM15766-treated
mouse skin included IL-10 signaling, T- and B-cell signaling in
RA, IL-6 signaling and dendritic cell maturation (Figure 7B). As
observed in vitro, we identified upregulation of TLR (Figure 7C,
Table S4) and interferon signaling networks (Figure 7D, Table S4)
in 7-DHC - treated mouse skin.
As shown in Figures 7E-L, real-time PCR confirmed the
microarray data showing that innate immune response genes,
specifically TLR and IFN genes are significantly upregulated with
sterol treatment. We observed that TLR4 (,3-fold, p,0.05), TLR6
(,3-fold, p,0.05), IFNa1 (,1.4-fold, p,0.01), IFNa7 (,1.5-fold,
p,0.01) and NFkB (,1.7-fold, p,0.05) were significantly
upregulated in BM15766-painted mouse skin. In contrast, TLR4
Figure 6. Sterol intermediates of cholesterol biosynthesis inhibit hair growth and activate the inflammatory response in C57BL/6J
mice. (A) Topical 7-DHC and (B) BM15766 treatment inhibited hair growth compared with vehicle treatment (ethanol or DMSO). Hair growth was
restored in vehicle-treated but not in 7-DHC and BM15766 treated mice. (C, D) Histology of mouse skin treated with ethanol, DMSO, 7-DHC and
BM15766 (20X). H&E staining of vehicle-treated mice showed normal hair follicles and sebaceous glands. In contrast, H&E staining of mice treated
with 7-DHC and BM15766 showed hyperkeratosis as well as dystrophic hair follicles and sebaceous glands. Scale bar=50 mm. (E, F) H&E staining
showed peri-follicular and inter-follicular inflammation in mouse skin that had been treated with 7-DHC (406). At higher magnification (1006),
infiltration of tissue histiocytes is observed. (G, F) A higher percentage of F4/80 cells was present in mouse skin treated with 7-DHC (Q5-LR) and
BM15766 (Q4-LR) than in the vehicle-treated mouse skin. See also Figures S3 and S4.
doi:10.1371/journal.pone.0038449.g006
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icantly upregulated in 7-DHC-painted mouse skin.
Discussion
The central finding of this study is that cholesterologenic
changes within hair follicle cells trigger an innate immune
response that leads to the induction of TLR and IFN gene
expression and the recruitment of macrophages that surround the
hair follicles and initiate their destruction.
Although PCA is a group of inflammatory hair disorders,
several unanswered but critical questions remain regarding the
nature and role of the inflammatory infiltrate in the natural history
of this disease. Several questions remain unanswered, including
whether the inflammatory reaction represents a primary or
secondary event in the disease pathogenesis, whether the in-
flammation is triggered by changes within hair follicles or by
exogenous factors (e.g., pathogens) and how much of the
inflammatory reaction reflects an autoimmune process. This study
provides a framework for addressing these complex issues.
Our data suggest that cholesterol precursors generated within
hair follicle cells trigger the initial inflammatory response and
induce the recruitment of tissue macrophages in mouse skin and in
PCA. These conclusions are based on several observations. Using
a global gene expression analysis, we first showed that the
expression of genes related to cholesterol biosynthesis is signifi-
cantly decreased in unaffected and affected scalp tissue from PCA
patients, which suggests that these expression changes are early
events in the pathogenesis of this disease. We further demonstrated
that innate and adaptive immune genes and pathways are
upregulated in lesional tissue, and there is a reciprocal expression
pattern of cholesterologenic and inflammatory gene expression in
PCA. Our data suggest that changes in expression of cholesterol
biosynthesis genes are a hallmark of all PCA subtypes and underlie
the pathogenesis of this group of alopecia. Our previous studies
Figure 7. Inflammatory pathways and networks activated in C57BL/6J mouse skin after topical treatment with 7-DHC and
BM15766. (A) The most significant signaling pathways altered by 7-DHC treatment participated in the inflammatory and immune responses and
were identified using IPA. Fisher’s exact test was used to calculate p values to determine the probability that the association between the genes in
the dataset and the pathway could be explained by chance alone. The yellow line indicates the threshold of significance (p,0.05) and represents the
ratio of the number of molecules from the data set that map to the pathway to the total number of molecules that map to the pathway. (B) The top
differentially regulated pathways in BM15766-treated mouse skin. The majority of the upregulated pathways participated in the inflammatory and
immune responses. (C, D) The top two predicted networks in 7DHC-treated mouse skin, determined using IPA. The TLR4 and IFN gene networks are
significantly upregulated by 7-DHC. Solid lines denote direct relationships between genes. Dotted lines denote an indirect relationship between two
genes. A red node denotes an upregulated gene, and a green node denotes a downregulated gene. See also Table S4. Real-time PCR validation of (E)
TLR4, (F) TLR6, (G) IFNa, (H) IFNa7, (I) NFkB, (J) IFNc, (K) MMD and (L) MCP1 gene expression in mouse skin treated with 7-DHC or BM15766 compared
with vehicle-treated (ethanol or DMSO) controls (n=3; *p,0.05, **p,0.01). The unpaired t-test was used for the statistical analysis. Treatment with 7-
DHC and BM15766 can induce the expression of some or all of these genes.
doi:10.1371/journal.pone.0038449.g007
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knockout mice (a mouse model of scarring alopecia) have
decreased expression of lipid metabolic genes and increased
expression of inflammatory genes suggesting that these changes are
caused by loss of PPARc signaling [10].
Based on our current observation that the cholesterol bio-
synthesis pathway is decreased in all PCA subtypes, we explored
the possibility of a mechanistic link between cholesterol bio-
synthesis and the inflammatory response in PCA. We treated hair
follicle cells in vitro with BM15766, a cholesterol biosynthesis
inhibitor, or 7-DHC, a cholesterol precursor, and we observed
that these substances induced a pro-inflammatory response with
increased expression of TLR and IFN genes. Our findings that the
TLR4 gene network is activated after treatment with 7-DHC and
that the TLR6 network is activated after treatment with BM15766
(causes accumulation of 7-DHC & 8-DHC) may help to explain
the pathogenesis of PCA. Our data suggest that different sterols
induce diverse chemokine and cytokine profiles. These observa-
tions are relevant to PCA because different sterols generated in the
subtypes of PCA may contribute to the clinical and histological
differences among the different disease entities.
We next asked whether the association between cholesterol
biosynthesis and the inflammatory response observed in vitro
could be reproduced upon treatment with BM15766 or 7-DHC in
vivo. Intriguingly, the expression of TGFb1, a catagen inducer
[13] was significantly upregulated both in HHFORS cells and in
mouse skin after treatment with BM15766. In addition, the
expression of SOX9, a hair follicle bulge stem cell marker [14] was
significantly downregulated in both human hair follicle cells and in
mouse skin upon treatment with 7-DHC and BM15766. A
histological analysis of the mouse skin that had been treated with
BM15766 and 7-DHC showed follicular plugging, epidermal
thickening and an inflammatory infiltrate in the inter-follicular
dermis. These data suggest that inhibition of cholesterol bio-
synthesis with BM15766 or treatment with the intermediate 7-
DHC inhibits hair growth and arrests the hair growth cycle in
mouse skin. F4/80 staining of the inflammatory infiltrate showed
that macrophages are the first inflammatory cells to appear upon
treatment of mouse skin with BM15766 or 7-DHC. Intriguingly,
we observed the CD68+ staining of scalp tissue from patients with
neutrophilic and lymphocytic PCA, which suggests a role for
macrophages in the pathogenesis of PCA.
We further observed that BM15766 and 7-DHC-treated mice
express prominent transcriptional signatures related to TLR and
IFN signaling in their skin. TLRs are inflammatory molecules that
bridge the innate and adaptive immune systems in humans and
activate multiple inflammatory pathways [13–15]. TLRs co-
ordinate the systemic defense against pathogens and may
recognize self-lipids, proteins and endogenous nucleic acids [16].
Data originating predominantly from animal models of autoim-
mune disease and anecdotal data from human patients suggest
that the inappropriate activation of TLR pathways by endogenous
or exogenous ligands may lead to the initiation and/or perpetu-
ation of autoimmune responses and tissue injury. TLRs in non-
immune cells have been implicated in multiple autoimmune and
inflammatory diseases, including Hashimoto’s thyroiditis (TLR3 in
thyrocytes) [17], colitis (TLR4 in intestinal epithelial cells [18] and
type 1 diabetes (TLR3 in pancreatic ß-cells) [19]. In each case, the
pathological expression of the TLR in non-immune cells is
associated with an autoimmune/inflammatory disease. Therefore,
the induction of TLRs by 7-DHC and BM15766 in hair follicle
cells in vitro and in mouse skin in vivo in the present study is
a novel observation.
We demonstrated that the inhibition of cholesterol biosynthesis
or treatment with cholesterol precursors in hair follicle cells
induces the expression of IFN and its target genes in mouse skin
and in tissue from patients with PCA. Intriguingly, the gene
expression profiling of tissue from patients with LPP, CCCA, FFA
and TF revealed the upregulation of interferon genes in all
subtypes. However, an ‘‘interferon-responsive signature’’ of in-
terferon target genes was clearly detected in LPP. Our data show
for the first time that LPP has an gene expression signature that is
related to the ‘‘interferon response’’ that is commonly observed in
autoimmune diseases [20]. Analyses of additional samples may be
necessary to identify similar signatures in other PCA subtypes. The
‘‘interferon response signature’’ is emerging as a common di-
agnostic feature of diverse autoimmune diseases, such as type 1
diabetes (T1D) [21], autoimmune thyroid disease [22], systemic
lupus erythematosus (SLE) [23], rheumatoid arthritis (RA) [24],
scleroderma [25], Sjogren’s syndrome [26], dermatomyositis [27]
and psoriasis [28], as well as animal models of autoimmune
diseases. Our data show a direct link between sterols and the
activation of the TLR and IFN signaling pathways in mouse skin
and in LPP. The TLR and IFN gene expression signatures in PCA
are similar to those observed in many autoimmune diseases.
However, it remains to be determined if PCA are indeed
autoimmune diseases.
In conclusion, our data suggest that cholesterologenic changes
are the primary events in the pathogenesis of PCA and trigger an
inflammatory response in human hair follicle cells and in mouse
skin. One mechanism by which sterol precursors might induce the
expression of TLR and IFN genes could be via the activation of
liver X receptors (LXR). LXRs are nuclear receptors activated by
sterol intermediates of cholesterol biosynthesis [29]. They function
as cholesterol sensors and regulators [30] and also control
transcriptional programs involved in the inflammatory response.
Although LXR has been reported to have anti-inflammatory
effects [31,32], LXR-dependent gene expression is important for
macrophage survival and the innate immune response [33], [34–
36].
Cholesterol is a multifunctional molecule that acts as an
essential membrane component, a cofactor for signaling molecules
and a precursor of steroid hormones [37,38]. Although its role in
the skin and skin appendages is incompletely understood,
cholesterol is essential for epidermal barrier function [39] and
forms an integral component of the hair follicle [40]. Several
human malformation syndromes are caused by inherited enzyme
defects in cholesterol biosynthesis and lead to a deficiency of
cholesterol as well as increased levels of bioactive or toxic
precursor sterols [41]. Three of these syndromes, CHILD,
CDPX2 and desmosterolosis, exhibit multiple cutaneous abnor-
malities, including alopecia, and there are reports of scarring
alopecia in patients with CDPX2 [41]. Recent studies by Evers
et al [42] described hair growth defects in an Insig-deficient mouse
model. These mice display defects in postnatal hair follicle cycling
that result from the accumulation of cholesterol precursors; the
defects could be rescued after treatment with simvastatin. Despite
these reports, the role of cholesterol and other lipids in the
pathogenesis of cutaneous disorders is not fully appreciated. Our
study shows a direct link between the sterol precursors of
cholesterol biosynthesis and hair disease in humans and may have
implications for other skin and hair diseases that are immune-
mediated, but whose mechanisms remain poorly defined.
This study reveals a previously unknown role for sterol
intermediates of cholesterol biosynthesis in PCA pathogenesis
and identifies a novel link between skin sterols and inflammation
that may prove transformative in the diagnosis and treatment of
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pathway is impaired in the skin and hair follicles of PCA patients.
Furthermore, investigations of PCA therapies should consider skin
sterol levels as a potential therapeutic target and as a disease
biomarker. A promising therapeutic strategy for PCA could be the
restoration of cholesterol homeostasis in hair follicle cells by
clinically available agonists of PPARc or antagonists of LXR
which are nuclear receptors that modulate this pathway
[10,43,44].
Materials and Methods
Human Tissue
All research involving human subjects for this study has been
conducted with written approval by the Case Institutional Review
Board (IRB Protocol Number: 08-05-03). For research involving
human participants, informed written consent has been obtained
and all clinical investigation has been conducted according to the
principles expressed in the Declaration of Helsinki. The diagnosis
of PCA was based upon clinical observation and histopathologic
findings of a lymphocytic, neutrophilic or mixed-cell infiltrate in
the infundibular or the permanent portion of the hair follicles, as
previously described [5]. The patients recruited for this study had
early-active lesions that were judged to be clinically representative
of lymphocytic (LPP, FFA, CCCA), neutrophilic (TF, FD) or
mixed (DC) PCA. For microarray analysis, two 4-mm scalp
biopsies were obtained, one from the affected area of the scalp and
another from the clinically unaffected scalp. The affected biopsy
specimens were obtained from the ‘‘active border,’’ which is an
area with inflammation and retained (but decreased) hair follicles.
These samples were paired with samples from clinically unaffected
areas in the same patient. Scalp biopsy specimens from healthy
volunteers (age-, sex- and race-matched) were included as controls.
The normal controls examined had no evidence of hair or skin
disorders. Scalp biopsies were obtained from patients seen at the
clinics of the University Hospitals of Cleveland or at the University
of California at San Francisco. All patients had active disease with
itching, burning, pain, progressive hair loss, a positive pull test and
evidence of inflammation. The patients were 18 years or older and
were able to give informed consent, and the patients were
evaluated in a standard manner that included a medical history;
detailed hair questionnaire; treatment history; an examination of
the hair, scalp, and skin and scalp photographs. All biopsies were
performed under the approval of the Institutional Review Board
and after appropriate consent had been obtained from patients
and volunteers. All tissue samples were stored at 280uC until
processed. These biopsies were utilized for total RNA extraction,
microarray analysis and real-time PCR.
Animals
All animal work has been conducted according to relevant
national and international guidelines. All animal protocols for this
study have been conducted with written approval by the Case
Western Reserve University Institutional Animal Care and Use
Committee (IACUC). Female C57BL/6J mice (Jackson Labora-
tory, Bar Harbor, Maine), aged 7 weeks, were randomly
distributed into four groups. They were housed in groups of 5
with standard diet food pellets and water available ad libitum.
Depilation to synchronize the hair cycle was performed as
previously published [45,46]. All of the hairs in the head region
were removed by shaving, followed by treatment with a depilatory
agent (Nair
TM hair remover, Church and Dwight Co. Inc.
Princeton, NJ, USA) to reveal pink skin. To compare the effects of
different treatments on the hair cycle, the mice were treated
topically with vehicle alone, with the sterol intermediate 7-DHC
(Sigma-Aldrich, St. Louis, Missouri) or with the cholesterol
biosynthesis inhibitor BM15766 (Sigma-Aldrich, St. Louis, Mis-
souri) for 15 days. Each mouse was treated topically (painted every
day on the head region) with the vehicle alone (ethanol: water 1:1)
or with 25 mM 7-DHC. The other animals were treated with
vehicle alone (DMSO: water 1:1) or with 4 mM BM15766. After
15 days of topical treatment, the mice were euthanized. Skin from
the painted region was harvested and stored at 280uC for
microarray and qRT-PCR analysis or embedded in paraffin for
histological sectioning. The sections were stained with hematoxylin
& eosin (H&E) using standard protocols for histological analysis.
Human Hair Follicle Outer Root Sheath Cells (HHFORS
cells)
HHFORS cells (ScienCell Research Laboratories, Carlsbad,
CA) were grown in mesenchymal stem cell media (ScienCell
Research Laboratories, Carlsbad, CA) with growth supplements
(heat-inactivated FBS, penicillin, streptomycin and mesenchymal
stem cell growth supplement) per the manufacturer’s instructions.
Third- or fourth-passage cells were seeded at a density of 0.6610
6
cells per p100 plate. Ethanol was used to dissolve 7-DHC (Sigma-
Aldrich, St. Louis, Missouri), and BM15766 (Sigma-Aldrich, St.
Louis, Missouri) was dissolved in DMSO. The final ethanol and
DMSO concentrations never exceeded 0.1% and did not affect the
experiments. HHFORS cells in serum-free medium were treated
with 7DHC, BM15766 or vehicle alone. A literature search
revealed that the effects of 7-DHC and BM15766 had not been
previously studied in HHFORS cells. We therefore conducted
time- and concentration-varying treatments using the VybrantH
MTT Cell Proliferation Assay Kit (Invitrogen, Grand Island, NY;
data not shown) to determine the optimal concentrations of 7-
DHC (25 mM), BM15766 (4 mM) or vehicle alone and the optimal
time of treatment (16–24 hours) for these experiments. Harvested
cells were used for RNA isolation followed by microarray and RT-
PCR analysis.
RNA Isolation & Microarray Analysis
RNA isolation and microarray analysis were performed as
described previously [10]. The total RNA from each biopsy was
extracted using TRIzol reagent (Life Technologies, Inc., Gaithers-
burg, MD, USA) per the manufacturer’s instructions. The RNA
extraction was followed by purification using RNeasy Mini
columns (Qiagen, Inc., Valencia, CA, USA). The RNA was
quantified by spectrometry and used for microarray and real-time
PCR experiments. The microarray experiments were performed
with fresh frozen scalp tissue biopsies from patients with LPP
(paired affected N=6 & unaffected N=5), CCCA (paired affected
N=3 and unaffected N=3), FFA (paired affected N=3 and
unaffected N=3) and TF (paired affected N=4 and unaffected
N=3). These samples were compared to normal (control) scalp
tissue (N=10, pooled) by interrogating the Affymetrix GeneChip
oligonucleotide array Human U133 Plus 2.0 (Affymetrix, Santa
Clara, CA). Human hair follicle cells treated with 7-DHC and
BM15766 were used for RNA isolation with the RNeasy Mini
column and microarray analysis with the HG U133 Plus 2.0
Array.
The Mouse Gene 1.0 ST Array (Affymetrix, Santa Clara, CA)
used for our studies provided whole-transcript coverage. Each of
the 28,853 genes is represented on the array by approximately 27
probes spread across the full length of the gene to provide a more
complete and accurate picture of gene expression than that
possible with 3’-based expression array designs. Sense DNA targets
were generated from as little as 100 ng of total RNA isolated from
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7-DHC (N=5) and BM15766 (N=5) were compared with
vehicle-treated controls.
Hybridization to the oligonucleotide arrays and subsequent
washing and detection were performed as described in the
Affymetrix Expression Analysis Technical Manual (Affymetrix).
Array images were acquired using a GeneChip Scanner 3000
(Affymetrix), and the images were analyzed with the Genechip
Operating Software (GCOS) and Expression Console. The image
from each GeneChip was scaled such that the average intensity for
all of the arrays was adjusted to a target intensity of 500 arbitrary
units to account for the inherent differences between the chips and
their hybridization efficiencies. The GeneChip array analysis
yielded the hybridization intensity for each represented gene as the
signal intensity. A multi-group Significance Analysis of Micro-
arrays (SAM) approach [47] was undertaken to select a set of genes
that was consistently differentially expressed among the unaffected
and affected PCA and healthy scalp skin, with a false discovery
rate (FDR) of ,0.003. The difference between PCA and the
normal controls was defined as significant for a 2-fold or greater
difference in the average hybridization signal intensity with
p,0.05 using a two-tailed unpaired t-test.
The Ingenuity Pathways Analysis (IPA) application (Ingenuity
Systems, www.ingenuity.com) was used to identify functional
significance, cellular location, and role in various biological and
metabolic processes of the selected gene products. Details of the
analytic methods and IPA data interpretation have been pre-
viously described [10]. Partek Genomics Suite (Partek Inc., St.
Louis, Missouri) was used for hierarchical clustering and principal
component analyses. Microarray data files from affected, un-
affected and normal samples were imported into Partek for
principal component analysis. All of the data sets were subjected to
multi-way ANOVA, and transcripts with signals differing among
groups with a certainty greater than p#0.05 were selected for
further study. A hierarchical cluster analysis was performed with
Pearson’s dissimilarity and complete linkage.
Quantitative Real-time RT-PCR
FAM-labeled PCR primers and TaqMan hydrolysis probes for
all target genes and 18S rRNA or transferrin receptor (TFRC)
controls were purchased from Applied Biosystems (Life Tech-
nologies Corporation, Carlsbad, California). Real-time PCR was
performed on an ABI StepOne
TM Sequence Detection System
(Applied Biosystems, Carlsbad, California) according to the
recommendations of the manufacturer. The expression of the
target genes in all samples, including PCA (LPP, CCCA, FFA,
DC, DF and TF) samples, control samples and samples from
mice treated with 7-DHC, BM15766 or vehicle were quantified
by the DDCT method, as described in the ABI StepOne
TM
Sequence Detection System manual (Applied Biosystems, Carls-
bad, California).
Histological Analysis
Mice treated with 7DHC and BM15766 were euthanized, and
skin samples from the head region were harvested and placed in
formalin overnight. Fixed skin samples were embedded in paraffin
according to procedures used for routine histology and stained
with H&E. For immunostaining of macrophages in PCA paraffin
sections, CD68 mouse monoclonal antibodies (ab955; diluted
1:100; Abcam, Cambridge, MA) were used. Macrophages in
paraffin-embedded sections of mouse skin tissue were detected
using rat monoclonal antibodies to F4/80 (ab6640; diluted 1:100;
Abcam, Cambridge, MA). Twenty-four-bit images were captured
at 206 and 406 on an Olympus BX-60 upright microscope
attached to a Retiga Exl Aqua camera (Q imaging Vancouver,
BC).
F4/80 Staining of Mouse Skin and Flow Cytometry
Cell suspensions were prepared from mouse skin that had been
painted with the sterol intermediate 7-DHC or with the cholesterol
inhibitor BM15766. Isolated cells were washed with RPM1/5%
FBS and re-suspended in the same medium. The cells were
counted and used for F4/80 flow cytometry. The cells were
incubated with FC blocker (eBiosciences, San Diego, CA) for
20 min. After 20 minutes, the anti-mouse F4/80 antigen Alexa
FluorH 647 (eBioscience, San Diego, CA) or propidium iodide (BD
Pharmingen San Diego, CA) was added. The samples were
incubated for 30 minutes at 4uC with rotation. After 30 min,
samples were washed with PBS twice and filtered with a 40-mm
cell strainer. The filtered samples were analyzed with flow
cytometry using the Accuri V6 flow cytometer (Ann Arbor, MI).
Supporting Information
Figure S1 Schematic representation of the cholesterol
biosynthesis pathway. Cholesterol biosynthesis involves the
coordinated regulation of .20 enzymatic reactions. The early
steps in endogenous cholesterol biosynthesis involve the conversion
of acetyl-CoA to mevalonic acid via HMG-CoA. Statins inhibit
the enzyme HMG-CoA reductase. The late steps involve the
conversion of lathosterol to 7-dehydrocholesterol (7-DHC). The
enzyme DHCR7 then converts 7-DHC to cholesterol. The
cholesterol biosynthesis inhibitor BM15766 is a pharmacological
inhibitor of the enzyme DHCR7.
(TIF)
Figure S2 Real-time PCR validation of TGFb1and SOX9
gene expression in HHFORS cells and in mouse skin
(*p,0.05, **p,0.01) after treatment with 7-DHC and
BM15766. Compared with untreated samples, TGFb1 gene
expression was significantly increased both in HHFORS cells and
in mouse skin after treatment with BM15766. No significant
change in TGFb1 gene expression was observed after treatment
with 7-DHC. In contrast, SOX9 gene expression was significantly
decreased both in HHFORS cells and in mouse skin after
treatment with BM15766 and with 7-DHC. The unpaired t-test
was used for statistical analysis.
(TIF)
Figure S3 F4/80 staining of mouse tissue after treat-
ment with 7-DHC and BM15766. Macrophages in paraffin-
embedded sections of mouse skin were detected using rat
monoclonal antibodies to F4/80. Infiltration of macrophages
was observed in mouse skin treated with 7-DHC and BM15766,
but not in vehicle-treated controls (ethanol and DMSO). Twenty-
four-bit images were captured at 206 and 406 on an Olympus
BX-60 upright microscope attached to a Retiga Exl Aqua camera
(Q Imaging, Vancouver, BC).
(TIF)
Figure S4 CD68 staining of paraffin sections of normal
scalp tissue and scalp tissue from patients with PCA
(LPP, CCCA, FFA, and TF). CD68+ cells were clearly observed
in LPP, CCCA and TF; fewer CD68+ cells were observed in FFA.
Twenty-four-bit images were captured at 406 on an Olympus
BX-60 upright microscope attached to a Retiga Exl Aqua camera
(Q Imaging, Vancouver, BC).
(TIF)
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genes is decreased in PCA. The degree of change of 14
differentially expressed cholesterol biosynthesis genes in LPP,
CCCA, FFA and TF is shown (N=10 for each subtype). Although
cholesterol biosynthesis genes are downregulated in all subtypes of
PCA, different sets of genes are downregulated in different
subtypes.
(TIF)
Table S2 Interferon response genes in PCA. The expres-
sion of interferon signaling genes in LPP, CCCA, FFA and TF is
shown. The expression of these genes in samples from patients
with PCA is compared with that in normal tissue. Interferon
response genes are significantly upregulated in LPP. Fewer
interferon-responsive genes are differentially expressed in the
other PCA subtypes. (ND= No change detected.)
(TIF)
Table S3 Expression of genes in the TLR4 and TLR6
networks. The TLR4- and TLR6-predicted networks were
generated using IPA. The identity of the genes and the degree
of change in the TLR4 network (Figure 5C) induced by treatment
of HHFORS cells with 7-DHC and in the TLR6 network
(Figure 5D) after treatment of HHFORS cells with BM15766 are
shown.
(TIF)
Table S4 Expression of genes in the TLR and IFN
networks that are activated upon treatment of mouse
skin with 7-DHC. The identity of the genes and the degree of
changes in the TLR and IFN networks that are activated after
treatment of mouse skin with 7-DHC are shown. Several
inflammatory genes, including interferon responsive genes, are
upregulated in both networks.
(TIF)
Glossary S1 A list of all abbreviations, gene symbols
and gene names included in the manuscript are shown
in the glossary.
(PDF)
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